Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Okuma

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Endocrinology|August 1, 1989
Studies on prolactin and growth hormone gene expression in the pituitary gland of spontaneous dwarf ratsH Nogami, T Takeuchi, K Suzuki, et al.
Scientific Reports|January 29, 2022
Critical behavior of nonequilibrium depinning transitions for vortices driven by current and vortex densityT Kaji, S Maegochi, K Ienaga, et al.
International Journal of Cancer|March 15, 1971
Lysosomes of rat liver and DAB carcinogenesisT Takano, N Kato, S Kunimoto-Miyata, et al.
Endocrinology|January 1, 1990
Molecular mechanism of growth hormone (GH) deficiency in the spontaneous dwarf rat: detection of abnormal splicing of GH messenger ribonucleic acid by the polymerase chain reactionT Takeuchi, H Suzuki, S Sakurai, et al.
Nihon Kyobu Shikkan Gakkai Zasshi|March 1, 1996
[Sarcomatous malignant mesothelioma diagnosed after death]S Okuma, M Kashara, M Kuroda, et al.
Japanese Journal of Pharmacology|September 28, 1998
Irsogladine maleate may preserve gastric mucosal hydrophobicity against ethanol in phospholipids independent way in ratsY Tatsumi, M Tanino, T Kodama, et al.
Transfusion|July 1, 1991
Er(a-) red cell phenotype in JapanK Naoki, S Okuma, E Uchiyama, et al.
Pathology|April 26, 2025
Primary mesenteric sarcoma with MGA::NUTM1 gene rearrangement: a case report and review on the emerging subset of NUTM1-rearranged neoplasmsNoorjehan Omar, Akihiko Yoshida, Hitomi S Okuma, et al.
Nature Communications|November 24, 2018
Vortex rectenna powered by environmental fluctuationsJ Lustikova, Y Shiomi, N Yokoi, et al.
Cancer Science|November 9, 2017
Potential utility of a longitudinal relative dose intensity of molecularly targeted agents in phase 1 dose-finding trialsAkihiro Hirakawa, Kan Yonemori, Fumie Kinoshita, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Endocrinology|August 1, 1989
Studies on prolactin and growth hormone gene expression in the pituitary gland of spontaneous dwarf ratsH Nogami, T Takeuchi, K Suzuki, et al.
Scientific Reports|January 29, 2022
Critical behavior of nonequilibrium depinning transitions for vortices driven by current and vortex densityT Kaji, S Maegochi, K Ienaga, et al.
International Journal of Cancer|March 15, 1971
Lysosomes of rat liver and DAB carcinogenesisT Takano, N Kato, S Kunimoto-Miyata, et al.
Endocrinology|January 1, 1990
Molecular mechanism of growth hormone (GH) deficiency in the spontaneous dwarf rat: detection of abnormal splicing of GH messenger ribonucleic acid by the polymerase chain reactionT Takeuchi, H Suzuki, S Sakurai, et al.
Nihon Kyobu Shikkan Gakkai Zasshi|March 1, 1996
[Sarcomatous malignant mesothelioma diagnosed after death]S Okuma, M Kashara, M Kuroda, et al.
Japanese Journal of Pharmacology|September 28, 1998
Irsogladine maleate may preserve gastric mucosal hydrophobicity against ethanol in phospholipids independent way in ratsY Tatsumi, M Tanino, T Kodama, et al.
Transfusion|July 1, 1991
Er(a-) red cell phenotype in JapanK Naoki, S Okuma, E Uchiyama, et al.
Pathology|April 26, 2025
Primary mesenteric sarcoma with MGA::NUTM1 gene rearrangement: a case report and review on the emerging subset of NUTM1-rearranged neoplasmsNoorjehan Omar, Akihiko Yoshida, Hitomi S Okuma, et al.
Nature Communications|November 24, 2018
Vortex rectenna powered by environmental fluctuationsJ Lustikova, Y Shiomi, N Yokoi, et al.
Cancer Science|November 9, 2017
Potential utility of a longitudinal relative dose intensity of molecularly targeted agents in phase 1 dose-finding trialsAkihiro Hirakawa, Kan Yonemori, Fumie Kinoshita, et al.
Pageof 5